Danske Bank A S Trims Stake in Healthpeak Properties, Inc. $DOC

Danske Bank A S lowered its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 95.9% in the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 16,300 shares of the real estate investment trust's stock after selling 378,680 shares during the period. Danske Bank A S's holdings in Healthpeak Properties were worth $349,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. New York Life Investment Management LLC increased its stake in shares of Healthpeak Properties by 65.8% in the 4th quarter. New York Life Investment Management LLC now owns 156,086 shares of the real estate investment trust's stock worth $2,510,000 after acquiring an additional 61,952 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al boosted its stake in Healthpeak Properties by 176.0% during the fourth quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 320,040 shares of the real estate investment trust's stock worth $5,146,000 after acquiring an additional 204,100 shares in the last quarter. Swedbank AB grew its holdings in Healthpeak Properties by 433.4% in the fourth quarter. Swedbank AB now owns 849,215 shares of the real estate investment trust's stock worth $13,655,000 after purchasing an additional 690,000 shares during the period. Nan Fung Trinity HK Ltd. purchased a new stake in Healthpeak Properties in the fourth quarter worth about $2,654,000. Finally, JPMorgan Chase & Co. grew its holdings in Healthpeak Properties by 8.6% in the fourth quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust's stock worth $493,251,000 after purchasing an additional 2,438,278 shares during the period. Hedge funds and other institutional investors own 93.57% of the company's stock.

Healthpeak Properties Stock Up 0.9%

NYSE:DOC opened at $21.40 on Friday. The company has a debt-to-equity ratio of 1.06, a quick ratio of 3.02 and a current ratio of 3.02. The firm has a market cap of $14.76 billion, a P/E ratio of 61.14, a P/E/G ratio of 2.50 and a beta of 1.01. Healthpeak Properties, Inc. has a fifty-two week low of $15.70 and a fifty-two week high of $22.95. The firm has a 50-day simple moving average of $21.38 and a two-hundred day simple moving average of $19.02.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.05. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The firm had revenue of $771.58 million for the quarter, compared to the consensus estimate of $725.64 million. During the same quarter in the prior year, the firm posted $0.46 earnings per share. The business's revenue was up 11.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Analysts predict that Healthpeak Properties, Inc. will post 1.77 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be issued a $0.1017 dividend. This represents a c) dividend on an annualized basis and a yield of 5.7%. The ex-dividend date is Monday, September 14th. Healthpeak Properties's payout ratio is presently 348.57%.

Analysts Set New Price Targets

DOC has been the subject of several recent research reports. Evercore lowered shares of Healthpeak Properties from an "outperform" rating to an "in-line" rating and set a $21.00 target price for the company. in a report on Monday, May 11th. Wells Fargo & Company upped their price target on Healthpeak Properties from $20.00 to $22.00 and gave the stock an "equal weight" rating in a research note on Wednesday, July 15th. Barclays initiated coverage on Healthpeak Properties in a research report on Tuesday, July 7th. They set an "equal weight" rating and a $23.00 price objective for the company. UBS Group lifted their price objective on Healthpeak Properties from $19.00 to $21.50 and gave the company a "neutral" rating in a research note on Wednesday, July 8th. Finally, Raymond James Financial started coverage on Healthpeak Properties in a report on Wednesday, June 17th. They issued a "market perform" rating on the stock. Four equities research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $21.66.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source